Correlation
The correlation between AMPH and MA is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
AMPH vs. MA
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Mastercard Inc (MA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or MA.
Performance
AMPH vs. MA - Performance Comparison
Loading data...
Key characteristics
AMPH:
-0.99
MA:
1.58
AMPH:
-1.38
MA:
2.07
AMPH:
0.83
MA:
1.30
AMPH:
-0.60
MA:
1.93
AMPH:
-1.26
MA:
8.31
AMPH:
30.84%
MA:
3.89%
AMPH:
39.69%
MA:
21.25%
AMPH:
-64.63%
MA:
-62.67%
AMPH:
-60.45%
MA:
-0.14%
Fundamentals
AMPH:
$1.21B
MA:
$527.78B
AMPH:
$2.76
MA:
$14.46
AMPH:
9.32
MA:
40.50
AMPH:
2.77
MA:
2.32
AMPH:
1.66
MA:
18.16
AMPH:
1.61
MA:
78.65
AMPH:
$728.26M
MA:
$29.07B
AMPH:
$365.89M
MA:
$22.22B
AMPH:
$255.58M
MA:
$17.36B
Returns By Period
In the year-to-date period, AMPH achieves a -30.76% return, which is significantly lower than MA's 11.55% return. Over the past 10 years, AMPH has underperformed MA with an annualized return of 5.00%, while MA has yielded a comparatively higher 20.91% annualized return.
AMPH
-30.76%
7.66%
-43.11%
-39.26%
-11.54%
6.64%
5.00%
MA
11.55%
7.13%
10.22%
31.76%
18.55%
14.89%
20.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. MA — Risk-Adjusted Performance Rank
AMPH
MA
AMPH vs. MA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Mastercard Inc (MA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AMPH vs. MA - Dividend Comparison
AMPH has not paid dividends to shareholders, while MA's dividend yield for the trailing twelve months is around 0.48%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MA Mastercard Inc | 0.48% | 0.50% | 0.53% | 0.56% | 0.49% | 0.45% | 0.44% | 0.53% | 0.58% | 0.74% | 0.66% | 0.51% |
Drawdowns
AMPH vs. MA - Drawdown Comparison
The maximum AMPH drawdown since its inception was -64.63%, roughly equal to the maximum MA drawdown of -62.67%. Use the drawdown chart below to compare losses from any high point for AMPH and MA.
Loading data...
Volatility
AMPH vs. MA - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 11.45% compared to Mastercard Inc (MA) at 4.93%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than MA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AMPH vs. MA - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Mastercard Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. MA - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.25M and revenue of 170.53M. Therefore, the gross margin over that period was 50.0%.
MA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Mastercard Inc reported a gross profit of 5.56B and revenue of 7.25B. Therefore, the gross margin over that period was 76.7%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported an operating income of 37.29M and revenue of 170.53M, resulting in an operating margin of 21.9%.
MA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Mastercard Inc reported an operating income of 4.15B and revenue of 7.25B, resulting in an operating margin of 57.2%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported a net income of 25.29M and revenue of 170.53M, resulting in a net margin of 14.8%.
MA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Mastercard Inc reported a net income of 3.28B and revenue of 7.25B, resulting in a net margin of 45.2%.